Understanding Heart Plaque in Young Adults: What CT Imaging Reveals About Premature Coronary Artery Disease

Table of Contents

• Key Points
• What Is Premature Coronary Artery Disease?
• Why This Research Matters
• How the Study Was Conducted
• Understanding the Key Imaging Terms
• Key Findings: What the Researchers Discovered
• Clinical Implications: What This Means for Patients
• Study Limitations: What This Study Couldn't Prove
• Recommendations: What Patients Can Do
• Frequently Asked Questions
• Source Information

Key Points

• Premature CAD is aggressive, with recurrences often from new lesions, not prior treatment sites.
• In 106 patients, premature CAD had significantly more non-calcified plaque than matched controls.
• High-risk plaque features were more common: positive remodeling 41.5% vs 9.4%, low attenuation 24.5% vs 3.8%.
• Patients with ischemic recurrence averaged 4.3 high-risk plaques vs 1.5 without recurrence.
• CCTA plaque assessment may improve risk stratification beyond traditional cardiovascular risk factors.

What Is Premature Coronary Artery Disease?

Coronary artery disease occurs when the arteries that supply blood to the heart muscle become narrowed or blocked by a buildup of plaque—a mixture of fat, cholesterol, calcium, and other substances found in the blood. When this disease develops at or before age 45, doctors call it premature coronary artery disease.

Premature CAD is different from the typical heart disease seen in older adults. "It is an aggressive disease with multiple recurrences mostly related to new coronary lesions," the authors explain. This means that even after successful treatment—such as stenting or bypass surgery—patients frequently develop new blockages in different locations, not just re-narrowing at the original treatment site.

Despite its serious consequences, doctors have historically had a limited understanding of exactly what the plaque looks like in these younger patients. Are the plaques harder and more calcified, or softer and more vulnerable to rupture? The answer to this question could fundamentally change how these patients are monitored and treated.

Why This Research Matters

Traditional risk factors—such as smoking, high cholesterol (dyslipidaemia), family history, and high blood pressure—help doctors identify who is at risk for heart disease. However, these factors alone do not fully explain why some patients with premature CAD experience repeated cardiac events while others remain stable.

The authors of this study hypothesized that the type of plaque may be the missing piece of the puzzle. If premature CAD is characterized by a specific, easily identifiable plaque pattern on a CT scan, doctors could potentially use that information to identify which young patients need more aggressive treatment.

This study is among the first to comprehensively compare the plaque characteristics of patients with premature CAD against a matched control group using advanced CT imaging, providing a detailed "phenotype" (observable characteristics) of the disease.

How the Study Was Conducted

Researchers screened 1,552 consecutive individuals who underwent CCTA at their institution. From this large group, they identified 106 individuals with a history of acute or stable obstructive CAD diagnosed at or before age 45.

To ensure a fair comparison, these 106 patients were then matched—one-to-one—with 106 control individuals who had incidental coronary plaques but no history of overt cardiovascular disease. The matching was performed according to five critical factors:

• Age
• Sex (sex)
• Smoking status
• Cardiovascular heredity (family history of heart disease)
• Dyslipidaemia (abnormal blood lipid/cholesterol levels)

This matching process is important because it ensures that any differences found between the two groups are likely due to the presence of premature CAD itself, rather than differences in age, gender, or risk factor profiles.

All CCTA scans were then analyzed for:

• CAD-RADS score (Coronary Artery Disease Reporting and Data System)—a standardized scoring system that categorizes the severity of coronary artery narrowing
• Plaque composition—whether plaques were calcified (hard), non-calcified (soft), or partially calcified (mixed)
• High-risk plaque (HRP) features, including four specific characteristics described below

In total, the researchers compared the characteristics of 348 plaques from patients with premature CAD against 167 incidental plaques found in the matched controls.

Patients were then followed for a median of 24 months (interquartile range 16–34 months) to track the occurrence of ischaemic recurrence (repeated heart events caused by reduced blood flow, such as heart attacks or unstable angina requiring hospitalization).

Understanding the Key Imaging Terms

To fully appreciate the findings, it helps to understand the four high-risk plaque features that the CT scans were looking for. These features are considered "high-risk" because they indicate a plaque that is more likely to rupture and cause a heart attack:

1. Spotty calcification—Small, scattered flecks of calcium within a plaque. Unlike large, dense calcium deposits which can stabilize a plaque, spotty calcification is associated with vulnerable, unstable plaque.
2. Positive remodelling—A process where the artery wall expands outward to accommodate a growing plaque. While this sounds harmless, it means the plaque does not narrow the artery significantly at first, making it "invisible" to traditional stress tests. However, positively remodelled plaques are often inflamed and prone to rupture.
3. Low attenuation—Areas within a plaque that appear very dark on CT imaging, indicating a large lipid (fat) or necrotic (dead tissue) core. These "soft" plaques are much more dangerous than hard, calcified plaques.
4. Napkin-ring sign—A specific imaging pattern where a ring of high density surrounds a low-density core. This sign is a strong indicator of a thin-cap fibroatheroma, the most dangerous type of vulnerable plaque.

Key Findings: What the Researchers Discovered

How many people had non-calcified plaques?

The most striking difference between the two groups was in plaque composition. Only 30.2% of control individuals had non-calcified plaques, compared to 65.1% of individuals with premature CAD (P < 0.001). In other words, premature CAD patients were more than twice as likely to carry soft, vulnerable plaques in their coronary arteries.

This means the vast majority of plaque buildup in young heart disease patients is not the hard, calcified type that is easily visible on standard screening tests. Instead, it is the soft, lipid-rich type that is more likely to rupture and cause acute cardiac events.

Every High-Risk Plaque Feature Was More Common in Premature CAD

The differences in individual high-risk plaque features were dramatic. As shown in the table below, each of the four features was significantly more prevalent in the premature CAD group:

• Spotty calcification: 42.5% of premature CAD patients vs. only 17.9% of controls (P < 0.001)
• Positive remodelling: 41.5% of premature CAD patients vs. only 9.4% of controls (P < 0.001)—a more than four-fold difference
• Low attenuation: 24.5% of premature CAD patients vs. only 3.8% of controls (P < 0.001)—a more than six-fold difference
• Napkin-ring sign: 1.9% of premature CAD patients vs. 0.0% of controls

None of the control participants exhibited a napkin-ring sign, making it an extremely specific marker of advanced, vulnerable disease in young patients.

High-Risk Plaque Burden

When the researchers counted the total number of high-risk plaques per person, the premature CAD group carried an average of 2.2 (standard deviation 2.7) high-risk plaques per individual. The control group, by contrast, displayed an average of only 0.4 (standard deviation 0.8) high-risk plaques (P < 0.001). This five-fold difference highlights that premature CAD is not just a disease of one vulnerable spot—it is a widespread, systemic process affecting multiple locations throughout the coronary tree.

High-Risk Plaques Predict Future Events

Perhaps the most clinically important finding relates to patient outcomes. During the median follow-up of 24 months, 24 individuals with premature CAD experienced an ischaemic recurrence (a repeat heart attack, unstable angina, or another event related to reduced blood flow).

These 24 patients had an average of 4.3 (standard deviation 3.9) high-risk plaques at their initial CT scan. In contrast, those who did not experience a recurrence had an average of only 1.5 (standard deviation 1.9) high-risk plaques.

Furthermore, the plaques in the recurrence group were mostly non-calcified with low attenuation and positive remodelling—the hallmarks of unstable, rupture-prone lesions.

Additionally, the graphical abstract of the study notes that more individuals with premature CAD had non-obstructive lesions with at least one high-risk plaque feature compared to controls. This is a crucial observation because non-obstructive lesions (blockages that narrow less than 50% of the artery) often go undetected in routine testing, yet they can still rupture and cause heart attacks.

Clinical Implications: What This Means for Patients

The authors draw a clear conclusion: "Coronary atherosclerosis in individuals with premature CAD is characterized by a high and predominant burden of non-calcified plaque and unusual high prevalence of HRP, contributing to disease progression with multiple recurrences."

In simpler terms, the arteries of young heart disease patients are fundamentally different from what doctors might expect. The disease is dominated by soft, vulnerable plaque that is difficult to detect with traditional testing such as exercise stress tests, which only detect significant blockages—not the presence of dangerous but non-obstructive plaque.

The authors further suggest that "a comprehensive qualitative CCTA assessment of plaque characteristics may further risk stratify our patients, beyond cardiovascular risk factors." In plain language, this means that looking inside the plaque with advanced CT imaging could help doctors determine which young patients are at the highest risk of future events—information that traditional risk factor assessment alone cannot provide.

For patients, this has several practical implications:

• A standard "normal" stress test does not rule out the presence of dangerous plaque, especially in young patients with risk factors
• CCTA provides unique information about plaque quality (soft vs. hard) that other tests cannot offer
• The number of high-risk plaques appears to correlate with future risk—more high-risk plaques mean higher risk of recurrence
• Treatment decisions may eventually be guided by plaque phenotype (the specific appearance and composition of the plaque)

Study Limitations: What This Study Couldn't Prove

While this study provides valuable insights, it is important to acknowledge its limitations.

First, this was an observational study, not a randomized trial. The researchers observed associations between plaque features and outcomes, but they cannot prove that modifying one specific plaque feature would prevent future events.

Second, the sample size for the outcome analysis was modest. Only 24 patients experienced an ischaemic recurrence during follow-up. While the differences between those with and without recurrence were notable, larger studies would provide more robust confirmation of these findings.

Third, the follow-up period was relatively short at a median of 24 months. Premature CAD is a lifelong disease, and longer-term outcomes may reveal additional patterns not visible in this timeframe.

Fourth, the matching process, while careful, cannot eliminate all potential confounding factors. Although patients were matched for five major risk factors, other variables—such as diet, physical activity, medication adherence, or genetic differences—could not be fully controlled.

Finally, the napkin-ring sign was observed in 0.0% of controls and only 1.9% of premature CAD patients. This low prevalence means its exact predictive value could not be rigorously assessed statistically with this sample size.

Recommendations: What Patients Can Do

Based on this research and current cardiology guidelines, here are practical recommendations for patients living with or at risk for premature CAD:

1. Discuss CCTA with your cardiologist. If you were diagnosed with heart disease at or before age 45, ask whether a coronary CT angiogram (CCTA) could provide additional information about the type of plaque in your arteries. This is especially relevant if you have unexplained symptoms or a history of recurrent events.
2. Do not rely solely on stress tests. Stress tests are good at detecting significant blockages but can miss non-obstructive, high-risk plaques. The study found that premature CAD patients frequently have non-obstructive lesions with dangerous plaque features.
3. Aggressively manage cardiovascular risk factors. The study matched participants for smoking, dyslipidaemia, and family history, confirming these factors are prevalent in this population. If you smoke, seek help to quit. Work with your doctor to optimize your cholesterol levels, blood pressure, and blood sugar.
4. Take medication adherence seriously. Statins and other lipid-lowering therapies have been shown to stabilize vulnerable plaques, converting them from high-risk to more stable forms. Ask your doctor how your current medications are affecting your plaque.
5. Understand that recurrence is not inevitable. While premature CAD is aggressive and recurrent, the study also shows that not all patients experience recurrence. Those who did had a higher burden of high-risk plaques, suggesting that identifying and treating this subgroup aggressively may change outcomes.
6. Advocate for comprehensive care. Young heart disease patients often fall through the cracks because "you're too young for heart disease" is a common myth. Seek care at a center experienced in managing premature CAD and ask about cardiac rehabilitation programs tailored to younger patients.

Frequently Asked Questions

What is premature coronary artery disease?

Premature coronary artery disease (CAD) is heart disease diagnosed at or before age 45. It is aggressive and often recurs, usually due to new blockages in different locations, not re-narrowing at previous treatment sites. It involves plaque buildup in coronary arteries, and traditional risk factors like smoking, high cholesterol, and family history are common.

What did the CT imaging study find about plaque in young heart disease patients?

In a study of 106 people with premature CAD and 106 matched controls, patients with premature CAD had far more non-calcified (soft) plaque and high-risk plaque features like spotty calcification, positive remodeling, and low attenuation. These features make plaques more likely to rupture and cause heart attacks, helping explain repeated cardiac events.

What are high-risk plaque features on a CT scan?

High-risk plaque features include spotty calcification (small scattered calcium flecks), positive remodeling (outward artery expansion hiding the plaque), low attenuation (dark areas indicating a lipid or necrotic core), and napkin-ring sign (a dense ring around a low-density core). These indicate vulnerable plaque more likely to rupture.

Why might a stress test miss dangerous plaque in young patients?

Stress tests detect significant blockages, but premature CAD patients often have non-obstructive lesions with high-risk plaque features. These lesions narrow the artery less than 50%, so they may not reduce blood flow enough to be detected, yet they can still rupture and cause heart attacks.

How many high-risk plaques did patients with recurrence have?

During a median follow-up of 24 months, 24 premature CAD patients experienced an ischemic recurrence. Those patients had an average of 4.3 high-risk plaques on their initial CT scan, while those without recurrence averaged only 1.5. Most plaques in the recurrence group were non-calcified with low attenuation and positive remodeling.

Can a coronary CT angiogram (CCTA) help manage premature CAD?

Yes, a CCTA provides detailed information about plaque type—soft versus hard—and high-risk features. The study suggests this assessment may help risk-stratify young patients beyond traditional risk factors. Patients diagnosed at or before age 45 can discuss with their cardiologist whether CCTA could offer useful information about their plaque.

What should young heart disease patients do based on this research?

Patients should discuss CCTA with their cardiologist, not rely solely on stress tests, aggressively manage risk factors like smoking and cholesterol, take medications like statins seriously to stabilize plaque, and seek comprehensive care. Recurrence is not inevitable, and identifying high-risk plaque burden may guide more aggressive treatment.

I had a heart attack at 40 and my CT scan showed soft plaque. Should I get a second opinion on my coronary artery disease treatment?

Yes, a second opinion can be valuable. This research shows that premature coronary artery disease, diagnosed at or before age 45, often involves non-calcified, high-risk plaque that may not be detected by stress tests. A detailed CCTA assessment of plaque type can help risk-stratify patients beyond traditional risk factors. If you have had recurrent events or are unsure about your treatment plan, an independent expert review of your imaging and management options may provide clarity. Diagnostic Detectives Network provides independent expert second opinions.

Source Information

This patient-friendly article is based on the following peer-reviewed research publication:

Original Article Title: Phenotyping coronary plaque by computed tomography in premature coronary artery disease European Heart Journal - Cardiovascular Imaging Oxford Academic

Journal: European Heart Journal – Cardiovascular Imaging, Volume 25, Issue 2, February 2024, Pages 257–266

DOI: https://doi.org/10.1093/ehjci/jead212

Published: 19 August 2023

Note: This patient-friendly article is based on peer-reviewed research. It is intended for educational purposes only and does not constitute medical advice. Patients should consult their healthcare providers with questions about their individual diagnosis, treatment options, and risk factors.